AstraZeneca plans to negotiate with Medicare over price of Farxiga

, September 26, 2023
Pharma

Farxiga — which is used to treat type 2 diabetes, as well as heart failure and chronic kidney disease — was among the first 10 drugs selected by CMS.

Merck COVID drug linked to virus mutations that can spread between people

, September 26, 2023
Pharma

A new study released Monday said Merck's widely used antiviral COVID pill can cause mutations in the virus that occasionally spread to other people.

The big pharma stock trade: Weight loss is in, COVID-19 is out

, September 26, 2023
Pharma

Wall Street sees blockbuster sales in weight loss for years to come.

The world needs new antibiotics, but the business model is broken

, September 26, 2023
Pharma

New drugs to defeat "superbug" bacteria aren't reaching patients.

Weight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100B by 2035

, September 25, 2023
Pharma

The global market for novel weight-loss drugs like Novo Nordisk A/S's Ozempic and Wegovy is poised to reach $100 billion by 2035 as patients start to understand the efficacy of the medications.

FDA panel votes against GLP-1 therapy from former diabetes unicorn Intarcia

, September 22, 2023
Pharma

An advisory panel to the FDA unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA twice rejected the implant.

Pages